Infection Control in the ICU Environment

Inbunden, Engelska, 2001

2 089 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This volume provides details of the most common infection control problems facing intensive care units. Contributing authors include noted scientists, intensivists and epidemiologists from the US and Europe, as well as infection control experts from the Centres for Disease Control and Prevention. Acinetobacter, methicillin resistant staphylococcus aureus and vancomycin resistant enterococci are examined in detail. The book also includes cutting-edge information regarding the potential for prophylactic and pre-emptive therapy of fungal infections in intensive care units. Innovations in vascular catheter care and prevention of bloodstream infections are discussed in this volume as well as up-to-date information in mathematical modelling to understand the epidemiology and control of infections in intensive care units.

Produktinformation

Utgivningsdatum2001-12-31
Mått155 x 235 x 21 mm
Vikt606 g
FormatInbunden
SpråkEngelska
SeriePerspectives on Critical Care Infectious Diseases
Antal sidor276
Upplaga2002
FörlagKluwer Academic Publishers
ISBN9780792374152

Tillhör följande kategorier

Sjukdomar och rubbningar inom Medicin
Medicin: allmänt inom Medicin
Samhällsmedicin och preventiv medicin inom Medicin
Olycksfalls- och akutmedicin inom Medicin
Patologi inom Medicin

1. Scope and Magnitude of Nosocomial ICU Infections U.S. Perspective:.- 2. Scope xand Magnitude of Nosocomial ICU Infections European Perspective:.- 3. Vancomycin-Resistant Enterococci: A Threat for the ICU? U.S. Perspective:.- 4. Vancomycin-Resisitant Enterococci in Europe: A Changing Epidemiology? European Perspective:.- 5. Methicillin-Resistant Staphylococcus Aureus: Is Control Necessary? U.S. Perspective:.- 6. Acinetobacter: Epidemiology and Control U.S. Perspective:.- 7. Acinetobacter: Epidemiology and Control European Perspective:.- 8. Fungal Infections: The Role of Prophylactic and Empiric Antifungal Therapy in ICU Patients U.S. Perspective:.- 9. Fungal Infections: The Role of Prophylaxis and Empiric Therapy in ICU Patients European Perspective:.- 10. Newer Approaches to Preventing Vascular Catheter-Related Sepsis U.S. Perspective:.- 11. Newer Approaches to Preventing Intravascular Device-Related Bloodstream Infections European Perspective:.- 12. Is Prevention of Ventilator-Associated Pneumonia Cost Effective? North American Perspective:.- 13. Ventilator-Associated Pneumonia: Is Prevention Cost Effective? European Perspective:.- 14. Cross-Colonization in Intensive Care Units: Fact or Fiction? U.S. Perspective:.- 15. Cross-Colonization: Fact or Fiction? European Perspective:.- 16. Conventional Infection Control Measures: Value or Ritual? U.S. Perspective:.- 17. Conventional Infection Control Measures: Value or Ritual? European Perspective:.- 18. Modeling of Antibiotic Resistance in the ICU U.S. Perspective:.- 19. Mathematical Models in the ICU: Dynamics, Infection Control and Antibiotic Resistance European Perspective:.